Trial intelligence / Profile preview

CS-747S clinical pharmacology study

jRCT2080221011Phase 2Completed

Sponsor
Daiichi Sankyo Co., Ltd.
Start
Feb 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 2 trial of prasugrel in Noncardioembolic stroke (NCES) (2 arms), sponsored by Daiichi Sankyo Co., Ltd. Started Feb 2010; status: completed.

02

Drugs

prasugrel
03

Conditions

Noncardioembolic stroke (NCES)

Beyond the preview

Go deeper on jRCT2080221011.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT2080221011.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call